In consistence with our results, the present study demonstrated that the expression of APP and BACE1 was significantly elevated in the HMD treated mice, while the expression of NEP and IDE proteins was downregulated, which suggested that the HMD caused AD-like symptoms were related to the production and metabolic pathways of Aβ. This evidence concerns the gene APP and Alzheimer disease.